$0.79
2.09% yesterday
Nasdaq, Jun 27, 10:00 pm CET
ISIN
US7743741024
Symbol
RMTI

Rockwell Medical, Inc. Stock price

$0.79
-0.17 17.72% 1M
-1.35 62.99% 6M
-1.25 61.17% YTD
-0.97 54.99% 1Y
-0.71 47.19% 3Y
-20.44 96.27% 5Y
-175.76 99.55% 10Y
-32.32 97.61% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.02 2.09%
ISIN
US7743741024
Symbol
RMTI
Sector

Key metrics

Basic
Market capitalization
$27.1m
Enterprise Value
$19.8m
Net debt
$-7.3m
Cash
$17.3m
Shares outstanding
34.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.28 | 0.39
EV/Sales
0.20 | 0.28
EV/FCF
9.14
P/B
0.86
Financial Health
Equity Ratio
55.04%
Return on Equity
-1.47%
ROCE
1.34%
ROIC
-
Debt/Equity
0.32
Financials (TTM | estimate)
Revenue
$97.7m | $69.6m
EBITDA
$2.8m | $-2.9m
EBIT
$572.0k
Net Income
$-260.0k | $-7.2m
Free Cash Flow
$2.2m
Growth (TTM | estimate)
Revenue
12.83% | -31.43%
EBITDA
158.02% | -203.32%
EBIT
108.71%
Net Income
96.92% | -1,391.67%
Free Cash Flow
110.51%
Margin (TTM | estimate)
Gross
17.87%
EBITDA
2.81% | -4.14%
EBIT
0.59%
Net
-0.27% | -10.29%
Free Cash Flow
2.21%
More
EPS
$-0.01
FCF per Share
$0.06
Short interest
0.56%
Employees
244.00
Rev per Employee
$420.00k
Show more

Is Rockwell Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Rockwell Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Rockwell Medical, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Rockwell Medical, Inc. forecast:

Buy
88%
Hold
13%

Financial data from Rockwell Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
98 98
13% 13%
100%
- Direct Costs 80 80
4% 4%
82%
17 17
90% 90%
18%
- Selling and Administrative Expenses 17 17
13% 13%
17%
- Research and Development Expense - -
-
-
2.75 2.75
158% 158%
3%
- Depreciation and Amortization 2.17 2.17
19% 19%
2%
EBIT (Operating Income) EBIT 0.57 0.57
109% 109%
1%
Net Profit -0.26 -0.26
97% 97%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Rockwell Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rockwell Medical, Inc. Stock News

Neutral
Seeking Alpha
about 2 months ago
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Heather Hunter - SVP, Chief Corporate Affairs Officer Mark Strobeck - President & CEO Jesse Neri - CFO Conference Call Participants Ram Selvaraju - H.C. Wainwright Jeremy Pearlman - Maxim Group Operator Good morning, and welcome to Rockwell Medical's First Quarter 2025 Results Con...
Neutral
Business Wire
about 2 months ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces financial and operational results for the three months ended March 31, 2025.
Neutral
Business Wire
3 months ago
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the first quarter ended March 31, 2025 on Monday, May 12, 2025.
More Rockwell Medical, Inc. News

Company Profile

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

Head office United States
CEO Mark Strobeck
Employees 244
Founded 1995
Website www.rockwellmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today